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Joëlle Bizeau, Frédéric Gobeaux, Jean-Philippe Renault, Laurent Marichal, Patrick 
Guenoun, Isabelle Grillo, Frank Wien, Marie Rouquette, Didier Desmaële, Sinda 
Lepêtre, Patrick Couvreur, Fabienne Testard 
Introduction 
Although squalene-based drug nanoparticles have already shown their efficiency in 
vivo, little is actually known of their stability and fate in biological medium. Here, 
through in vitro physico-chemical characterizations we assess the evolution of 
Squalene-Adenosine nanoparticles (SqAd NPs) in presence of bovine serum albumin 
(BSA), the main protein component of plasma. 
Methods 
The NPs were prepared by nanoprecipitation of SqAd conjugate monomers 
solubilized in ethanol into an aqueous solvent. After ethanol removal, the NPs were 
mixed with phosphate buffer saline (PBS) and BSA. The NPs structure and stability 
was assessed by small angle neutron scattering (SANS) and cryo-transmission 
electron microscopy (cryoTEM). The nature of the interaction between SqAd and 
BSA was more specifically characterized by circular dichroism analysis, 
measurement of the fluorescence quenching of BSA and isothermal titration 
calorimetry (ITC). 
Results 
Colloidal stability of the nanoparticles – While SqAd NPs quickly aggregate in PBS, 
they are shown to be stable in presence of BSA. SANS measurements can be fitted 
by a distribution of spherical particles. Additionally, in presence of BSA, a decrease of 
the NP radius and of the volume fraction is observed. Likewise, cryoTEM 
observations of Sq-Ad NPs with BSA show a shift of the size distribution.  
Spectroscopic characterization of the SqAd – BSA interaction – In presence of SqAd 
NPs, the CD spectrum of BSA is modified, indicating a change in secondary 
conformation, in particular a decrease in the α-helix content. Likewise, the BSA 
fluorescence is quenched, showing the formation of a complex. Further 
characterization by ITC indicates an enthalpy-driven exothermic interaction. 
Discussion 
The colloidal stability of SqAd NPs is enhanced in presence of BSA. However, a 
significant decrease of radius is observed suggesting an extraction of the SqAd from 
the NPs. The spectroscopic analyses indeed show a specific interaction between the 
SqAd monomers and BSA. These results may have implication in the uptake and 
transport of bioactive squalenoid monomers in vivo. Indeed, they suggest that if the 
NPs act as a convenient reservoir to inject bioactive SqAd molecules, they are partly 
disassembled in the biological medium while the resulting monomers are carried 
along by serum albumin. 
 
